List of Tables
Table 1: Women’s Health Drugs Market, Global, Classification of Cervical Intraepithelial Neoplasia, 2018
Table 2: Women’s Health Drugs Market, Common Symptoms of the Perimenopause and Menopause, 2018
Table 3: Women’s Health Drugs Market, Global, Comparison of PCOS Diagnostic Criteria Classification Systems, 2018
Table 4: Women’s Health Drugs Market, 7MM, Prevalence of Endometriosis, Polycystic Ovarian Syndrome, and Women’s Infertility, 2017
Table 5: Women’s Health Drugs Market, Global, Types of Female Contraceptives, 2018
Table 6: Women’s Health Drugs Market, Global, Approved Women’s Health Indications for Premarin, 2018
Table 7: Women’s Health Drugs Market, Global, Approved Women’s Health Indications for Lupron/Lupron Depot, 2018
Table 8: Women’s Health Drugs Market, Global, Approved Women’s Health Indications for Gonal-F, 2018
Table 9: Women’s Health Drugs Market, Global, Approved Women’s Health Indications for Mirena, 2018
Table 10: Women’s Health Drugs Market, Global, Approved Women’s Health Indications for Celebrex, 2018
Table 11: Women’s Health Drugs Market, Global, Approved Women’s Health Indications for Implanon ,2018
Table 12: Women’s Health Drugs Market, Global, Approved Women’s Health Indications for Yasmin/Yaz, 2018
Table 13: Women’s Health Drugs Market, Global, Approved Health Indications for Nuvaring, 2018
Table 14: Women’s Health Drugs Market, Global, Approved Women’s Health Indications for Gardasil, 2018
Table 15: Women’s Health Drugs Market, Global, Approved Women’s Health Indications for Esmya, 2018
Table 16: Women’s Health Drugs Market, Global, Approved Women’s Health Indications for Orilissa, 2018
Table 17: Women’s Health Drugs Market, Global, Annual Revenue Forecast for Key Products ($m), 2017–2024 (part 1)
Table 18: Women’s Health Drugs Market, Global, Annual Revenue Forecast for Key Products ($m), 2017–2024 (part 2)
Table 19: Women’s Health Drugs Market, Global, Forecast Revenue by Company, 2017–2024